<?xml version="1.0"?>
<rss version="2.0" xml:base="link" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:fb="http://www.facebook.com/2008/fbml" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:media="http://www.rssboard.org/media-rss" xmlns:og="http://ogp.me/ns#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:schema="http://schema.org/" xmlns:sioc="http://rdfs.org/sioc/ns#" xmlns:sioct="http://rdfs.org/sioc/types#" xmlns:skos="http://www.w3.org/2004/02/skos/core#" xmlns:xsd="http://www.w3.org/2001/XMLSchema">
  <channel>
    <title>JD Health - South China Morning Post</title>
    <link>https://www.scmp.com/rss/517875/feed</link>
    <description>JD Health is the healthcare arm of e-commerce giant JD.com. It is the biggest online healthcare platform and retail pharmacy in China by revenue. The company's pharmaceutical and healthcare product retailing business, selling to both businesses and consumers, promises delivery within 30 minutes. It also offers online telemedicine, including specialist services and traditional Chinese medicine. The number of active users on its platform surpassed 168 million in June 2023.</description>
    <language>en</language>
    <image>
      <url>https://assets.i-scmp.com/static/img/icons/scmp-meta-1200x630.png</url>
      <title>JD Health - South China Morning Post</title>
      <link>https://www.scmp.com</link>
    </image>
    <atom:link href="https://www.scmp.com/rss/517875/feed" rel="self" type="application/rss+xml"/>
    <item>
      <author>Julie Zhang</author>
      <dc:creator>Julie Zhang</dc:creator>
      <description>At least 10 weight-loss injections and oral pills are lining up for regulatory approval in China, in a market projected to reach about US$14 billion by 2030.
Novo Nordisk’s blockbuster semaglutide, which generated about US$35 billion in global revenue last year, lost patent protection in China on March 20, clearing the way for rivals.
The rush comes as China’s drug regulator accelerates approvals of innovative therapies, helped by a surge in out-licensing deals with global pharmaceutical...</description>
      <guid isPermaLink="true">https://www.scmp.com/business/china-business/article/3347869/chinas-weight-loss-drug-makers-take-global-giants-novo-nordisk-patent-expires?utm_source=rss_feed</guid>
      <link>https://www.scmp.com/business/china-business/article/3347869/chinas-weight-loss-drug-makers-take-global-giants-novo-nordisk-patent-expires?utm_source=rss_feed</link>
      <pubDate>Thu, 26 Mar 2026 03:00:08 +0000</pubDate>
      <title>China’s weight-loss drug makers take on global giants as Novo Nordisk patent expires</title>
      <enclosure length="3000" type="image/jpeg" url="https://cdn.i-scmp.com/sites/default/files/styles/1280x720/public/d8/images/canvas/2026/03/25/1af1ac90-995f-435f-8b92-ad0233378e3c_a1054248.jpg?itok=Y4nGANmq&amp;v=1774431885"/>
      <media:content height="2001" medium="image" type="image/jpeg" url="https://cdn.i-scmp.com/sites/default/files/styles/1280x720/public/d8/images/canvas/2026/03/25/1af1ac90-995f-435f-8b92-ad0233378e3c_a1054248.jpg?itok=Y4nGANmq&amp;v=1774431885" width="3000"/>
    </item>
    <item>
      <author>Wency Chen,Zhang Tong</author>
      <dc:creator>Wency Chen,Zhang Tong</dc:creator>
      <description>China is counting on artificial intelligence (AI) to help the 450 million people living in rural areas left behind by the nation’s economic boom.
Farmers are already benefiting from the technology, using AI offerings such as DeepSeek or ByteDance’s Doubao for help with issues like pig rearing, pest control and government subsidies. The State Council’s “No 1 document” of 2026, extended a push for the “digital upgrading” of farming, with an emphasis on the greater integration of AI, drones, robots...</description>
      <guid isPermaLink="true">https://www.scmp.com/plus/tech/tech-trends/article/3346713/ai-narrow-chinas-rural-urban-economic-divide?utm_source=rss_feed</guid>
      <link>https://www.scmp.com/plus/tech/tech-trends/article/3346713/ai-narrow-chinas-rural-urban-economic-divide?utm_source=rss_feed</link>
      <pubDate>Mon, 16 Mar 2026 07:00:11 +0000</pubDate>
      <title>AI to narrow China’s rural-urban economic divide</title>
      <enclosure length="2480" type="image/jpeg" url="https://cdn.i-scmp.com/sites/default/files/styles/1280x720/public/d8/images/canvas/2026/03/16/a3f1f81d-8932-4386-8117-5c1173fc07bf_f5e3adbc.jpg?itok=-Zd1mf9n&amp;v=1773638226"/>
      <media:content height="3505" medium="image" type="image/jpeg" url="https://cdn.i-scmp.com/sites/default/files/styles/1280x720/public/d8/images/canvas/2026/03/16/a3f1f81d-8932-4386-8117-5c1173fc07bf_f5e3adbc.jpg?itok=-Zd1mf9n&amp;v=1773638226" width="2480"/>
    </item>
    <item>
      <author>Eunice Xu</author>
      <dc:creator>Eunice Xu</dc:creator>
      <description>Ant Group’s artificial intelligence health app AQ surpassed 100 million users during the Spring Festival holiday, the company said, underlining growing momentum in China’s AI-driven healthcare sector.
The app topped China’s Apple App Store overall download rankings for several consecutive days over the holiday period, according to Ant Group.
Ant Group attributed the surge in part to younger, tech-savvy consumers who, after returning home for Spring Festival gatherings, shared the app with their...</description>
      <guid isPermaLink="true">https://www.scmp.com/tech/article/3344359/ants-aq-health-app-breaks-through-100-million-users-amid-holiday-surge?utm_source=rss_feed</guid>
      <link>https://www.scmp.com/tech/article/3344359/ants-aq-health-app-breaks-through-100-million-users-amid-holiday-surge?utm_source=rss_feed</link>
      <pubDate>Mon, 23 Feb 2026 14:00:07 +0000</pubDate>
      <title>Ant’s AQ health app breaks through 100 million users amid holiday surge</title>
      <enclosure length="4096" type="image/jpeg" url="https://cdn.i-scmp.com/sites/default/files/styles/1280x720/public/d8/images/canvas/2026/02/23/0197cb51-ce00-4778-9cfe-17044cd6dfb0_87c78cc5.jpg?itok=digugc3F&amp;v=1771843965"/>
      <media:content height="2732" medium="image" type="image/jpeg" url="https://cdn.i-scmp.com/sites/default/files/styles/1280x720/public/d8/images/canvas/2026/02/23/0197cb51-ce00-4778-9cfe-17044cd6dfb0_87c78cc5.jpg?itok=digugc3F&amp;v=1771843965" width="4096"/>
    </item>
    <item>
      <author>Ji Siqi</author>
      <dc:creator>Ji Siqi</dc:creator>
      <description>When I woke up with a sore throat and fever in Beijing earlier this month, the last thing I wanted to do was go to a hospital.
Even though the nearest public facility is just a 15-minute walk from my flat, I didn’t have the energy to leave my bed, let alone endure the long queues, crowds and cumbersome procedures that come with a hospital visit. In fact, I suspected I had contracted the virus that was causing my symptoms from a trip to that very hospital four days earlier, as it was the only...</description>
      <guid isPermaLink="true">https://www.scmp.com/economy/china-economy/article/3336227/reporters-notebook-home-test-kit-takes-headache-out-beijing-healthcare?utm_source=rss_feed</guid>
      <link>https://www.scmp.com/economy/china-economy/article/3336227/reporters-notebook-home-test-kit-takes-headache-out-beijing-healthcare?utm_source=rss_feed</link>
      <pubDate>Sun, 14 Dec 2025 11:00:10 +0000</pubDate>
      <title>Reporter’s notebook: home test kit takes headache out of Beijing healthcare</title>
      <enclosure length="4095" type="image/jpeg" url="https://cdn.i-scmp.com/sites/default/files/styles/1280x720/public/d8/images/canvas/2025/12/12/d815172c-29d3-4760-84f6-6d192c894f5a_63f2a5ef.jpg?itok=dhYGA6T1&amp;v=1765530830"/>
      <media:content height="2730" medium="image" type="image/jpeg" url="https://cdn.i-scmp.com/sites/default/files/styles/1280x720/public/d8/images/canvas/2025/12/12/d815172c-29d3-4760-84f6-6d192c894f5a_63f2a5ef.jpg?itok=dhYGA6T1&amp;v=1765530830" width="4095"/>
    </item>
    <item>
      <author>Yulu Ao</author>
      <dc:creator>Yulu Ao</dc:creator>
      <description>Hong Kong stocks fell on Wednesday, tracking Wall Street’s retreat from record highs amid growing concerns that the artificial intelligence boom may have overheated and risks turning into a bubble.
The Hang Seng Index closed 0.5 per cent lower at 26,829.46. The Hang Seng Tech Index lost 0.6 per cent. Stock exchanges on the mainland are closed for a week-long public holiday and will reopen on Thursday.
Search-engine leader Baidu slumped 3 per cent to HK$135, while food-delivery service provider...</description>
      <guid isPermaLink="true">https://www.scmp.com/business/china-business/article/3328178/hong-kong-stocks-drop-most-2-weeks-amid-ai-bubble-fears-track-wall-street?utm_source=rss_feed</guid>
      <link>https://www.scmp.com/business/china-business/article/3328178/hong-kong-stocks-drop-most-2-weeks-amid-ai-bubble-fears-track-wall-street?utm_source=rss_feed</link>
      <pubDate>Wed, 08 Oct 2025 02:37:45 +0000</pubDate>
      <title>Hong Kong stocks fall as AI bubble fears grow amid Wall Street retreat</title>
      <enclosure length="4095" type="image/jpeg" url="https://cdn.i-scmp.com/sites/default/files/styles/1280x720/public/d8/images/canvas/2025/10/08/7d2a5152-83a4-4cbf-aad8-2f2ff704032a_9597228a.jpg?itok=cPxKUlRr&amp;v=1759890973"/>
      <media:content height="2483" medium="image" type="image/jpeg" url="https://cdn.i-scmp.com/sites/default/files/styles/1280x720/public/d8/images/canvas/2025/10/08/7d2a5152-83a4-4cbf-aad8-2f2ff704032a_9597228a.jpg?itok=cPxKUlRr&amp;v=1759890973" width="4095"/>
    </item>
    <item>
      <author>Yulu Ao</author>
      <dc:creator>Yulu Ao</dc:creator>
      <description>Hong Kong stocks fell on Thursday in the absence of catalysts ahead of the Federal Reserve’s annual Jackson Hole symposium.
The Hang Seng Index declined 0.2 per cent to 25,104.61 at the close of Thursday trading, after rising as much as 0.2 per cent. The Hang Seng Tech Index slipped 0.8 per cent. On the mainland, the CSI 300 Index added 0.4 per cent, while the Shanghai Composite Index advanced 0.1 per cent.
Search-engine leader Baidu slid 2.6 per cent to HK$85 after quarterly revenue fell by the...</description>
      <guid isPermaLink="true">https://www.scmp.com/business/china-business/article/3322592/hong-kong-stocks-fluctuate-investors-await-feds-jackson-hole-insights?utm_source=rss_feed</guid>
      <link>https://www.scmp.com/business/china-business/article/3322592/hong-kong-stocks-fluctuate-investors-await-feds-jackson-hole-insights?utm_source=rss_feed</link>
      <pubDate>Thu, 21 Aug 2025 03:13:18 +0000</pubDate>
      <title>Hong Kong stocks fall as investors await Fed’s Jackson Hole insights</title>
      <enclosure length="4095" type="image/jpeg" url="https://cdn.i-scmp.com/sites/default/files/styles/1280x720/public/d8/images/canvas/2025/08/21/f5fe0b21-835e-4705-b3b9-a60b3627d4ef_ee78cf66.jpg?itok=M03yecSN&amp;v=1755745914"/>
      <media:content height="2730" medium="image" type="image/jpeg" url="https://cdn.i-scmp.com/sites/default/files/styles/1280x720/public/d8/images/canvas/2025/08/21/f5fe0b21-835e-4705-b3b9-a60b3627d4ef_ee78cf66.jpg?itok=M03yecSN&amp;v=1755745914" width="4095"/>
    </item>
    <item>
      <author>Eric Ng</author>
      <dc:creator>Eric Ng</dc:creator>
      <description>Innovent Biologics, the first Chinese company to win regulatory approval to sell a GLP-1 drug for weight loss and diabetes, will leverage JD Health’s online distribution network as it seeks to grab a slice of a market that could be worth 40 billion yuan (US$5.6 billion) in a decade.
The companies will collaborate on supply chain and sales channel development ahead of Innovent’s launch of mazdutide, as well as engage in a consumer education campaign.
“Innovent and JD Health will join hands to...</description>
      <guid isPermaLink="true">https://www.scmp.com/business/article/3318242/chinas-ozempic-pioneer-inks-deal-jd-health-online-distribution?utm_source=rss_feed</guid>
      <link>https://www.scmp.com/business/article/3318242/chinas-ozempic-pioneer-inks-deal-jd-health-online-distribution?utm_source=rss_feed</link>
      <pubDate>Tue, 15 Jul 2025 06:30:07 +0000</pubDate>
      <title>‘China’s Ozempic’ pioneer inks deal with JD Health for online distribution</title>
      <enclosure length="3000" type="image/jpeg" url="https://cdn.i-scmp.com/sites/default/files/styles/1280x720/public/d8/images/canvas/2025/07/15/492993ae-06ad-4c24-80ae-772f53dff73b_91e0e909.jpg?itok=j8RPngW5&amp;v=1752556591"/>
      <media:content height="2001" medium="image" type="image/jpeg" url="https://cdn.i-scmp.com/sites/default/files/styles/1280x720/public/d8/images/canvas/2025/07/15/492993ae-06ad-4c24-80ae-772f53dff73b_91e0e909.jpg?itok=j8RPngW5&amp;v=1752556591" width="3000"/>
    </item>
    <item>
      <description>Chinese online shopping giant JD.com reported a 92 per cent year-on-year jump in quarterly net income to 12.6 billion yuan (US$1.7 billion), despite a flattish revenue, as better operational efficiencies helped the company navigate intensifying competition in the domestic e-commerce industry.
During the quarter ended June 30, the company achieved “growing economies of scale and procurement efficiencies” that allowed it to “bring users everyday low prices without sacrificing quality”, said chief...</description>
      <guid isPermaLink="true">https://www.scmp.com/tech/big-tech/article/3274632/jdcom-profit-surges-second-quarter-after-slashing-prices-installing-trade-programme?utm_source=rss_feed</guid>
      <link>https://www.scmp.com/tech/big-tech/article/3274632/jdcom-profit-surges-second-quarter-after-slashing-prices-installing-trade-programme?utm_source=rss_feed</link>
      <pubDate>Thu, 15 Aug 2024 10:45:38 +0000</pubDate>
      <title>JD.com profit surges in second quarter after slashing prices, installing trade-in programme</title>
      <enclosure length="4095" type="image/jpeg" url="https://cdn.i-scmp.com/sites/default/files/styles/1280x720/public/d8/images/canvas/2024/08/15/ea29a0ed-a0ee-4ad1-9e93-1b1e3623e304_34d047c0.jpg?itok=SvvADTdO&amp;v=1723718585"/>
      <media:content height="2730" medium="image" type="image/jpeg" url="https://cdn.i-scmp.com/sites/default/files/styles/1280x720/public/d8/images/canvas/2024/08/15/ea29a0ed-a0ee-4ad1-9e93-1b1e3623e304_34d047c0.jpg?itok=SvvADTdO&amp;v=1723718585" width="4095"/>
    </item>
    <item>
      <description>Four companies including JD Health International and Trip.com Group will join the Hang Seng Index starting next month, following the benchmark’s latest quarterly review.
China Resources Power Holdings and Zijin Mining Group will also be added to the benchmark of Asia’s third-largest stock market, taking the number of index constituents to 80 from 76 currently, with the changes taking effect on June 5, Hang Seng Indexes Company said in a statement on Friday night. The announcement comes after the...</description>
      <guid isPermaLink="true">https://www.scmp.com/business/china-business/article/3220405/jd-health-tripcom-join-hang-seng-index-next-month-compiler-resumes-additions-meet-its-100-member?utm_source=rss_feed</guid>
      <link>https://www.scmp.com/business/china-business/article/3220405/jd-health-tripcom-join-hang-seng-index-next-month-compiler-resumes-additions-meet-its-100-member?utm_source=rss_feed</link>
      <pubDate>Fri, 12 May 2023 13:00:23 +0000</pubDate>
      <title>JD Health, Trip.com to join Hang Seng Index next month, as compiler resumes additions to meet its 100-member target</title>
      <enclosure length="4095" type="image/jpeg" url="https://cdn.i-scmp.com/sites/default/files/styles/1280x720/public/d8/images/canvas/2023/05/12/6d4db4b9-1385-4eb6-9f90-76a6b17c41b3_d6a7e155.jpg?itok=7LNA1_Id&amp;v=1683896103"/>
      <media:content height="2652" medium="image" type="image/jpeg" url="https://cdn.i-scmp.com/sites/default/files/styles/1280x720/public/d8/images/canvas/2023/05/12/6d4db4b9-1385-4eb6-9f90-76a6b17c41b3_d6a7e155.jpg?itok=7LNA1_Id&amp;v=1683896103" width="4095"/>
    </item>
    <item>
      <description>Global funds seeking new investment flavours in Hong Kong’s stock market will have to live with more of the same as Chinese technology and healthcare companies are tipped to join the city’s benchmark index after a review this week.
Kuaishou, JD Health and Li Auto are among potential candidates to make it to the blue-chip index when the review is announced on Friday, according to the common picks at local brokerages including China Renaissance Securities and China International Capital Corp.
The...</description>
      <guid isPermaLink="true">https://www.scmp.com/business/banking-finance/article/3210737/hang-seng-index-review-likely-offer-more-same-kuaishou-jd-health-and-li-auto-tipped-increase-tech?utm_source=rss_feed</guid>
      <link>https://www.scmp.com/business/banking-finance/article/3210737/hang-seng-index-review-likely-offer-more-same-kuaishou-jd-health-and-li-auto-tipped-increase-tech?utm_source=rss_feed</link>
      <pubDate>Sun, 19 Feb 2023 23:30:20 +0000</pubDate>
      <title>Hang Seng Index: review likely to offer more of the same as Kuaishou, JD Health and Li Auto tipped to increase tech, pharma dominance</title>
      <enclosure length="4095" type="image/jpeg" url="https://cdn.i-scmp.com/sites/default/files/styles/1280x720/public/d8/images/canvas/2023/02/19/a0431ddb-e7e1-4e26-9a77-5ddab99c87d3_131c60a9.jpg?itok=nEiqQ2kx&amp;v=1676778424"/>
      <media:content height="2730" medium="image" type="image/jpeg" url="https://cdn.i-scmp.com/sites/default/files/styles/1280x720/public/d8/images/canvas/2023/02/19/a0431ddb-e7e1-4e26-9a77-5ddab99c87d3_131c60a9.jpg?itok=nEiqQ2kx&amp;v=1676778424" width="4095"/>
    </item>
    <item>
      <description>Chinese healthcare-related stocks tumbled in Hong Kong on speculation authorities are turning to online pharmaceutical platforms as the next focus of regulatory crackdown, erasing HK$40 billion (US$5 billion) of market value on Wednesday.
Alibaba Health Information sank 13.8 per cent to HK$4.79 at the close of Wednesday trading, the most in 11 months, while JD Health tumbled 14.8 per cent to HK$53.40, its worst drop in two months. A healthcare sub-gauge within the Hang Seng Composite Index...</description>
      <guid isPermaLink="true">https://www.scmp.com/business/markets/article/3182620/alibaba-health-jd-health-pull-chinese-healthcare-stocks-lower-amid?utm_source=rss_feed</guid>
      <link>https://www.scmp.com/business/markets/article/3182620/alibaba-health-jd-health-pull-chinese-healthcare-stocks-lower-amid?utm_source=rss_feed</link>
      <pubDate>Wed, 22 Jun 2022 06:30:34 +0000</pubDate>
      <title>Alibaba Health, JD Health pull Chinese healthcare stocks lower amid fears of a crackdown on online pharma platforms</title>
      <enclosure length="4095" type="image/jpeg" url="https://cdn.i-scmp.com/sites/default/files/styles/1280x720/public/d8/images/canvas/2022/06/22/d90409d5-7c86-4700-8e62-0be818cc5c73_0b3b763d.jpg?itok=_S9Ev7J-&amp;v=1655879368"/>
      <media:content height="2560" medium="image" type="image/jpeg" url="https://cdn.i-scmp.com/sites/default/files/styles/1280x720/public/d8/images/canvas/2022/06/22/d90409d5-7c86-4700-8e62-0be818cc5c73_0b3b763d.jpg?itok=_S9Ev7J-&amp;v=1655879368" width="4095"/>
    </item>
    <item>
      <description>Hong Kong stocks retreated from a two-week high technology stocks tumbled after some company insiders cut their stakes in Meituan and JD Health. The city faces heightened recession risks while traders brace for higher US interest rates.
The Hang Seng Index fell 1.1 per cent to 20,869.52 at the close of Wednesday trading, the biggest drop in a week, and bringing the decline this year to 11 per cent. The Tech Index slumped 3.3 per cent. Markets in mainland China are closed for a holiday.
Meituan...</description>
      <guid isPermaLink="true">https://www.scmp.com/business/markets/article/3176435/hong-kong-stocks-slump-meituan-leads-chinese-tech-retreat-after?utm_source=rss_feed</guid>
      <link>https://www.scmp.com/business/markets/article/3176435/hong-kong-stocks-slump-meituan-leads-chinese-tech-retreat-after?utm_source=rss_feed</link>
      <pubDate>Wed, 04 May 2022 02:30:55 +0000</pubDate>
      <title>Chinese tech stocks tumble as insiders sell Meituan, JD Health while Hong Kong faces recession risks, higher rates</title>
      <enclosure length="4095" type="image/jpeg" url="https://cdn.i-scmp.com/sites/default/files/styles/1280x720/public/d8/images/canvas/2022/05/04/a72a76ff-a5ab-4097-8022-6cb9d2b4669c_4ecbdcea.jpg?itok=6x_Y0ihO&amp;v=1651641360"/>
      <media:content height="2730" medium="image" type="image/jpeg" url="https://cdn.i-scmp.com/sites/default/files/styles/1280x720/public/d8/images/canvas/2022/05/04/a72a76ff-a5ab-4097-8022-6cb9d2b4669c_4ecbdcea.jpg?itok=6x_Y0ihO&amp;v=1651641360" width="4095"/>
    </item>
    <item>
      <description>JD Health, the health care arm of e-commerce giant JD.com, plans to use part of its listing proceeds to identify acquisition opportunities among the over 450,000 offline pharmacies in China, said chief executive Xin Lijun.﻿
The internet will become the primary means of medical consultation and initial assessment in China in five years’ time, as the coronavirus pandemic has led to a lasting change to how ordinary citizens use medical services and aftercare.
.JD Health is looking to buy...</description>
      <guid isPermaLink="true">https://www.scmp.com/business/banking-finance/article/3113051/jd-health-plans-use-part-hong-kong-ipo-proceeds-buy?utm_source=rss_feed</guid>
      <link>https://www.scmp.com/business/banking-finance/article/3113051/jd-health-plans-use-part-hong-kong-ipo-proceeds-buy?utm_source=rss_feed</link>
      <pubDate>Tue, 08 Dec 2020 10:00:10 +0000</pubDate>
      <title>JD Health plans to use part of Hong Kong IPO proceeds to buy offline pharmacies</title>
      <enclosure length="4267" type="image/jpeg" url="https://cdn.i-scmp.com/sites/default/files/styles/1280x720/public/d8/images/methode/2020/12/08/37282a16-392b-11eb-9b80-f4f1a4017c77_image_hires_174236.jpg?itok=a5-T1P83&amp;v=1607420564"/>
      <media:content height="2845" medium="image" type="image/jpeg" url="https://cdn.i-scmp.com/sites/default/files/styles/1280x720/public/d8/images/methode/2020/12/08/37282a16-392b-11eb-9b80-f4f1a4017c77_image_hires_174236.jpg?itok=a5-T1P83&amp;v=1607420564" width="4267"/>
    </item>
    <item>
      <description>JD Health, the health care arm of Chinese e-commerce giant JD.com, has priced its initial public offering (IPO) at HK$70.58 (US$9.1) per share, according to people familiar with the transaction, which will see it raise US$3.5 billion in Hong Kong’s second-largest deal this year.
The offer price was at the top-end of the price range, which had been marketed to investors at HK$62.8 to HK$70.58 a share. A listing on the main board is scheduled for Tuesday.
The total amount raised by JD Health ranks...</description>
      <guid isPermaLink="true">https://www.scmp.com/business/banking-finance/article/3112237/chinese-health-care-platform-jd-health-raises-us35-billion?utm_source=rss_feed</guid>
      <link>https://www.scmp.com/business/banking-finance/article/3112237/chinese-health-care-platform-jd-health-raises-us35-billion?utm_source=rss_feed</link>
      <pubDate>Wed, 02 Dec 2020 06:33:41 +0000</pubDate>
      <title>Chinese health care platform JD Health raises US$3.5 billion in Hong Kong’s second largest IPO this year</title>
      <enclosure length="5568" type="image/jpeg" url="https://cdn.i-scmp.com/sites/default/files/styles/1280x720/public/d8/images/methode/2020/12/02/e8684912-3441-11eb-8d89-a7d6b31c4b8a_image_hires_145925.jpg?itok=NoHNWGNW&amp;v=1606892376"/>
      <media:content height="3712" medium="image" type="image/jpeg" url="https://cdn.i-scmp.com/sites/default/files/styles/1280x720/public/d8/images/methode/2020/12/02/e8684912-3441-11eb-8d89-a7d6b31c4b8a_image_hires_145925.jpg?itok=NoHNWGNW&amp;v=1606892376" width="5568"/>
    </item>
    <item>
      <description>The initial public offerings of Evergrande Property Services and JD Health, both due to kick off this week, look set to push the total funds raised on the Hong Kong stock exchange to a 10-year high.
Deal arrangers are rushing to launch share sales in the remaining few weeks of 2020, a year characterised by fewer but more sizeable deals as investors chase Chinese issuers operating in the only country in the world forecast to post growth this year amid the global pandemic.
“While revenues at our...</description>
      <guid isPermaLink="true">https://www.scmp.com/business/banking-finance/article/3110968/listings-evergrande-property-services-jd-health-poised?utm_source=rss_feed</guid>
      <link>https://www.scmp.com/business/banking-finance/article/3110968/listings-evergrande-property-services-jd-health-poised?utm_source=rss_feed</link>
      <pubDate>Mon, 23 Nov 2020 06:30:16 +0000</pubDate>
      <title>Listings of Evergrande Property Services, JD Health poised to push Hong Kong’s funds raised via IPO to 10-year high</title>
      <enclosure length="3500" type="image/jpeg" url="https://cdn.i-scmp.com/sites/default/files/styles/1280x720/public/d8/images/methode/2020/11/23/87faf8b8-2d43-11eb-be20-200ca6256645_image_hires_184457.jpeg?itok=ahD5MT9_&amp;v=1606128317"/>
      <media:content height="2334" medium="image" type="image/jpeg" url="https://cdn.i-scmp.com/sites/default/files/styles/1280x720/public/d8/images/methode/2020/11/23/87faf8b8-2d43-11eb-be20-200ca6256645_image_hires_184457.jpeg?itok=ahD5MT9_&amp;v=1606128317" width="3500"/>
    </item>
    <item>
      <description>JD Health, the healthcare arm of e-commerce giant JD.com, is looking to raise up to US$3 billion via an initial public offering in Hong Kong later this year, according to people familiar with the process.
The Beijing-based online and offline healthcare retail group was last valued at around US$12 billion in August by investors. The company is still a relatively young unicorn, carved out of JD.com only last year.
JD Health is looking to file a listing application to the Hong Kong exchange this...</description>
      <guid isPermaLink="true">https://www.scmp.com/business/companies/article/3102054/jd-health-makes-us3-billion-ipo-appointment-hong-kong-later-year?utm_source=rss_feed</guid>
      <link>https://www.scmp.com/business/companies/article/3102054/jd-health-makes-us3-billion-ipo-appointment-hong-kong-later-year?utm_source=rss_feed</link>
      <pubDate>Fri, 18 Sep 2020 08:00:17 +0000</pubDate>
      <title>JD Health makes an US$3 billion IPO appointment in Hong Kong for later this year</title>
      <enclosure length="5000" type="image/jpeg" url="https://cdn.i-scmp.com/sites/default/files/styles/1280x720/public/d8/images/methode/2020/09/18/4431344a-f95d-11ea-a41c-8cbd1416100a_image_hires_152124.jpg?itok=3rqsnX1J&amp;v=1600413695"/>
      <media:content height="3333" medium="image" type="image/jpeg" url="https://cdn.i-scmp.com/sites/default/files/styles/1280x720/public/d8/images/methode/2020/09/18/4431344a-f95d-11ea-a41c-8cbd1416100a_image_hires_152124.jpg?itok=3rqsnX1J&amp;v=1600413695" width="5000"/>
    </item>
  </channel>
</rss>